Second Circuit Upholds Dismissal Of AstraZeneca Investor Suit

Second Circuit Upholds Dismissal of AstraZeneca Investor Suit; Southern District of New York Dismisses Stockholder Suit Against Array Technologies; Eastern District of New York Tosses Stockholder Class Action Based on Ericsson Bribery Investigation
Second Circuit Upholds Dismissal of AstraZeneca Investor Suit
On May 16, 2023, the US Court of Appeals for the Second Circuit affirmed the Southern District of New York’s order dismissing an action brought by investors of AstraZeneca PLC (AstraZeneca) attempting to hold the company liable for alleged […]

By | June 24th, 2023 ||

Tom Walsh Contributes To “InDepth Feature: Litigation & Alternative Dispute Resolution 2023”

Winston & Strawn Partner and Complex Commercial Litigation Practice Co-Chair Tom Walsh authored the United States chapter of “InDepth Feature: Litigation & Alternative Dispute Resolution 2023.” In the chapter Tom provides insights on key trends in commercial disputes in the United States, advice for companies implementing an effective dispute resolution strategy, and the issues and challenges expected for commercial disputes in the U.S. in the coming months.

Published by Financer WorldWide, “InDepth Feature: Litigation & Alternative […]

By | June 21st, 2023 ||

Kamaraju Explains Use Of Classified Info In Trials

Pryor Cashman Partner Sidhardha “Sid” Kamaraju, co-chair of the Regulatory Enforcement + Securities Litigation Practice, spoke with Politico about the rules around classified information and documents in trials.

In “How to hold a public trial when the key evidence is classified,” Sid explains that only certain people can have access to the info:

“Usually when you have cases involving classified information, there’s sort of a small bucket of defense lawyers who handle that because they either already have […]

By | June 20th, 2023 ||